Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TADA1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | ZCCHC3 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | SET | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-07 |
mRNA | MBNL2 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-07 |
mRNA | WDR75 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-07 |
mRNA | FZD3 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-07 |
mRNA | RP4-635E18.9 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
mRNA | POLA1 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
mRNA | RSBN1 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
mRNA | AL513122.2 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-07 |